Angiotensin-converting enzyme insertion/deletion gene polymorphism in lung cancer patients

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 7, 2012, Pages 722-725

  Dević Pavlić, Sanja ^a   Ristić, Smiljana ^a   Flego, Veljko ^b   Kapović, Miljenko ^a   Radojčić Badovinac, Andelka ^a,c  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c University of Rijeka   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; CROATIA; FEMALE; GENOTYPE; HUMAN; INDEL MUTATION; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CROATIA; FEMALE; HUMANS; INDEL MUTATION; LUNG NEOPLASMS; MALE; NEOPLASM PROTEINS; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 84863909970     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0306     Document Type: Article

References (24)

1. Altekruse SF, Kosary CL, Krapcho M, et al. (eds) SEER Cancer Statistics Review, 1975-2007, National Cancer Institute, Be-thesda, MD. Available at http://seer.cancer.gov/csr/1975-2007/, accessed October 14, 2011.
2. Brambilla E, Travis WD, Colby TV, et al. (2001) The new World Health Organization classification of lung tumors. Eur Respir J 18:1059-1068. (Pubitemid 34092881)
3. Croatian National Cancer Registry (2005-2009) Cancer incidence in Croatia 2003-2007. Bulletins no. 27-31. Zagreb: Croatian national institute of public health.
4. Castellon R, Hamdi HK (2007) Demystifying the ACE polymorphism: from genetics to biology. Curr Pharm Des 13:1191-1198. (Pubitemid 46739329)
5. Cheon KT, Choi KH, Lee HB, et al. (2000) Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung 178:351-360. (Pubitemid 32368237)
6. Escobar E, Rodŕiguez-Reyna TS, Arrieta O, et al. (2004) Angio-tensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Curr Vasc Pharmacol 2:385-399. (Pubitemid 39200189)
7. Feng Y, Wan H, Liu J, et al. (2010) The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer. Oncol Rep 23:941-948.
8. Flego V, Radojcic Badovinac A, Bulat Kardum L, et al. (2009) Primary lung cancer and TNF-alpha gene polymorphisms: a case-control study in a Croatian population. Med Sci Monit 15:361-365.
9. González-Zuloeta Ladd AM, Arias Vásquez A, Sayed-Tabata-baei FA, et al. (2005) Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:2143-2146.
10. Kiyohara C, Yoshimasu K, Takayama K, et al. (2006) EPHX1 polymorphisms and the risk of lung cancer: a HuGE review. Epidemiology 17:89-99.
11. Koh WP, Yuan JM, Sun CL, et al. (2003) Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 63:573-578.
12. Ljungberg L, Alehagen U, Länne T, et al. (2011) The association between circulating angiotensin-converting enzyme and cardiovascular risk in the elderly: a cross-sectional study. J Renin Angiotensin Aldosterone Syst 20:1-9.
13. Medeiros R, Vasconcelos A, Costa S, et al. (2004) Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 202:330-335. (Pubitemid 38325242)
14. Mountain CF (1997) Revisions in the International System for Staging Lung Cancer. Chest 111:1710-1717. (Pubitemid 27260107)
15. Nacak M, Nacak I, Sanli M, et al. (2010) Association of angio-tensin coverting enzyme gene insertion/deletion polymorphism with lung cancer in Turkey. Cancer Genet Cytogenet 198:22-26.
16. Prochazka J, Krepela E, Sedo A, et al. (1991) Aminopeptidases and angiotensin I-converting enzyme activities in primary human lung tumors and lung parenchyma. Neoplasma 38: 501-508.
17. Rigat B, Hubert C, Corvol P, et al. (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene (DCP1) (dipeptidyl carboxypeptidas 1). Nucleic Acids Res 20:1433.
18. Rooney C, Sethi T (2011) The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer. Respiration 81:89-104.
19. Saijonmaa O, Nyman T, Fyhrquist F (2005) Regulation of angiotensin-converting enzyme production by nicotine in human endothelial cells. Am J Physiol Heart Circ Physiol 289: 2000-2004.
20. Shanmugan V, Sell KW, Saha BK (1993) Mistyping ACE heterozygotes. PCR Methods Appl 3:120-121.
21. Tarnow L, Gluud C, Parving HH (1998) Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Nephrol Dial Transplant 13:1125-1130. (Pubitemid 28227184)
22. Ucar G, Yildirim Z, Ataol E, et al. (1997) Serum angiotensin converting enzyme activity in pulmonary diseases: correlation with lung function parameters. Life Sci 61:1075-1082. (Pubitemid 27371347)
23. Van der Knaap R, Siemens C, Coebergh JW, et al. (2008) Renin-angiotensin System inhibitors, Angiotensin I-converting enzyme gene insertion/deletion polymorphism and cancer: the Rotterdam Study. Cancer 112:748-757. (Pubitemid 351240568)
24. Yuan A, Yu CJ, Chen WJ, et al. (2000) Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int J Cancer 89:475-483.